MELTZER LESLIE 4
4 · Apellis Pharmaceuticals, Inc. · Filed Sep 2, 2025
Insider Transaction Report
Form 4
MELTZER LESLIE
Chief Research and Development
Transactions
- Award
Common Stock
2025-08-26+61,804→ 61,804 total - Award
Stock Option (Right to Buy)
2025-08-26+92,592→ 92,592 totalExercise: $16.20Exp: 2035-08-26→ Common Stock (92,592 underlying)
Footnotes (2)
- [F1]This restricted stock unit was granted on August 26, 2025. The restricted stock unit will vest 25% annually over four years from grant date, subject to her continued service as an officer, or upon later termination of her service.
- [F2]This represents a stock option award granted August 26, 2025 that vests over a four-year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.